InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,430.26
(
-0.02%
)
US TECH 100
19,191.47
(
0.12%
)
Dow Jones
38,548.83
(
-0.10%
)
Brent Oil
82.83
(
0.85%
)
Bitcoin
65,534.32
(
-1.66%
)
Post# of 461471
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

TempePhil

Send PM Follow Ignore
Followers 17
Posts 581
Boards Moderated 0
Alias Born 05/18/2018

TempePhil

Re: BIOChecker4 post# 158139

Tuesday, 07/17/2018 10:34:58 AM

Tuesday, July 17, 2018 10:34:58 AM

Post# of 461471
You posted "Granted, the patients/caregivers have requested to continue of the drug. That at least means the drug is benign..."

No, to me, and apparently to the patient/caregivers, that means it is benign AND they see it as worth taking AND worth the effort to request extension of their doses!

As far as your other postulate. From my discussion with the company, they are not interested in PR for stock price gains. Look for another reason.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Start posting your company's news
Only $200 per official company press release!